Indefinite Delivery Contract 36C25722D0051

Award Date 6/3/22
Last Date to Order 6/2/27
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Service Contract Act
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Department of Veterans Affairs (VA) has awarded Caredx, Inc., doing business as Caredx, a $1,963,141.20 single-award Indefinite Delivery Vehicle (IDV) contract to provide genetic blood testing services to support the VA's transplant programs. This IDV covers the supply of Caredx's AlloMap and AlloSure products, which are used to assess organ rejection risk in transplant patients. Under this IDV, the VA has issued multiple firm-fixed-price delivery orders to Caredx, including a $392,628.24...
The Department of Veterans Affairs (VA) Veterans Health Administration has awarded an Indefinite Delivery Contract (IDC) to Caredx, Inc., a for-profit organization, to provide AlloSure kidney testing kits and related services to support the VA's transplant programs. The initial IDC award, valued at $1,420,375, was made in September 2021 as a total small business set-aside. Under this contract, the VA has subsequently issued multiple delivery orders for AlloSure kidney testing, with individual...
The federal contract IDV award is for LAB TESTS FOR POST TRANSPLANT CARE, issued by the Department of Veterans Affairs (VA) to the prime contractor Caredx, Inc., a for-profit medical diagnostics company based in Brisbane, California. This is a single-award Indefinite Delivery Contract valued at $4,367,680.42 with a period of performance from April 1, 2025 to March 31, 2030. The contract aims to procure a range of specialized genetic and molecular testing services from Caredx, including the...
The federal contract IDV was awarded by the Department of Veterans Affairs, Network Contracting Office 23 to Caredx, Inc., a for-profit organization headquartered in Brisbane, California. The single-award, $724,391.25 Indefinite Delivery Contract is for AlloSure in-home patient testing services, which are used to assess organ rejection risks in transplant recipients. The contract covers a range of specialized genetic and molecular testing services, including AlloMap and AlloSure testing kits, as...
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a single-award indefinite delivery contract to Naveris Inc., a for-profit organization located in Waltham, Massachusetts, for NAVDX blood testing services. The contract, valued at a ceiling of $968,000.00, has an ultimate completion date of April 30, 2026. Two task orders have been issued under the IDC so far. The first task order, valued at $176,000.00, has a completion date of April 30, 2025 and is for NAVDX...
The U.S. Department of Veterans Affairs (VA), through its Veterans Integrated Service Network (VISN) 19, has awarded a series of Blanket Purchase Agreement (BPA) call contracts to Mdxhealth, Inc., a for-profit healthcare company specializing in molecular diagnostic services and cancer testing. The contracts, valued at over $500,000 total, are for the provision of MDX health testing and analysis services to support the VA's healthcare programs for veterans. The contracts were awarded under the...
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 8 (VISN 8) awarded a single-award indefinite delivery contract to Veterans Healthcare Supply Solutions, Inc., a Service-Disabled Veteran-Owned Small Business (SDVOSB), to provide real-time polymerase chain reaction (PCR) cancer detection and cost-per-test reagents. The contract has a total ceiling value of $842,310 and a period of performance through September 30, 2025. Under this...
This Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA), Network Contracting Office (NCO) 21, to Diacarta, Inc. for reference laboratory testing services to aid in the diagnosis of VEXAS Syndrome. The contract has a total ceiling value of $200,000 and a period of performance from October 1, 2024 to September 30, 2029. The key services under this contract include specimen pickup, testing for somatic mutations of the UBA1 gene, reporting, and consultation....
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 (VA - VHA VISN 21) awarded an Indefinite Delivery Contract (IDC) to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, to provide Abbott Alinity reagents, supplies, and related services. The single-award IDC has a potential value of $6.96M and a period of performance from October 1, 2021 through December 31, 2023. No set-asides were utilized. Under this IDC, the VA - VHA VISN 21...
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 17 (VISN 17) awarded an Indefinite Delivery Contract (IDC) to Navix Diagnostix, Inc. (Navix Diagnostix), a for-profit organization, for the provision of vascular laboratory services and accreditation. The single-award IDC, set aside for small businesses, has a potential value of $843,406 through December 2026 and includes a $205,464 option year delivery order for services in Temple,...
  • 36C25722D0051
    Indefinite Delivery Contract
  • 4
    Federal Contract Awards

The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network (VISN) 17 awarded a single-award indefinite delivery contract to Caredx Lab Solutions Inc., a subsidiary of Caredx Inc., to provide AlloMap molecular testing services for heart transplant recipients. The $675,000 IDC, which runs through June 2027 with no set-aside, establishes Caredx as the sole supplier of the FDA-approved AlloMap test to aid in post-transplant surveillance and patient management within VISN 17, headquartered in Dallas, Texas.

The VA has issued several firm-fixed-price delivery orders against this IDC, valued at $59,931.70, $64,800, and $6,480, to continue AlloMap testing services that enhance the VISN's capabilities to monitor organ transplant patients, including those at the Dallas VA Medical Center. Caredx, a leading provider of genomics-based solutions for transplant care, will deliver its proprietary AlloMap test, which detects cell-free DNA to assess heart transplant rejection risk, in support of the VHA's mission to deliver specialized healthcare to America's veterans.

Generated 5/7/24, 11:24 AM